Status:

COMPLETED

Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19

Lead Sponsor:

Holland Bloorview Kids Rehabilitation Hospital

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

8-13 years

Phase:

NA

Brief Summary

This study will examine if a virtual delivery of a group Cognitive Behavioural Therapy (CBT) program, specifically using "Facing Your Fears" (FYF) curriculum, is helpful in improving anxiety symptoms ...

Detailed Description

The research team will adapt the Facing Your Fears (FYF) program, in consultation with program developers, Canadian experts (psychologists) and Holland Bloorview's Research Family Engagement Committee...

Eligibility Criteria

Inclusion

  • Chronological age between 8 and 13 years (13 yr, 11 mos, 29 days)
  • Have a clinical diagnosis of Autism Spectrum Disorder (ASD)
  • Ability to read at a grade 2 level or above (based on parent report)
  • Verbally fluent at a grade 2 level or above (can speak or respond to questions that are appropriate for a child in grade 2; based on parent report)
  • Child with significant anxiety symptoms as determined by the clinical team
  • To enhance generalizability of our findings, children will be eligible if they present with some other co-morbid psychiatric conditions (see exclusion criteria)
  • If already receiving pharmacological interventions, must meet the following criteria: If receiving concomitant medications for anxiety, must be on a stable dose during the month prior to screening (6 weeks for fluoxetine).

Exclusion

  • Being currently enrolled in another active behavioral/ educational/ psychological treatment for anxiety
  • Diagnosis of acute psychosis or conduct disorder, or a primary diagnosis of Obsessive Compulsive Disorder without another anxiety diagnosis or clinically significant level of anxiety.

Key Trial Info

Start Date :

December 4 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2022

Estimated Enrollment :

101 Patients enrolled

Trial Details

Trial ID

NCT04666493

Start Date

December 4 2020

End Date

January 30 2022

Last Update

July 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Holland Bloorview Kids Rehabilitation Hospital

Toronto, Ontario, Canada, M4G 1R8